Navigation Links
North Carolina Marketing Firm MicroMass Named One of Top 60 Healthcare Agencies in U.S.
Date:7/15/2008

Rankings Published by Medical Marketing & Media

CARY, N.C., July 15 /PRNewswire/ -- MicroMass Communications, Inc., a leader in behavioral science-based relationship marketing, is ranked one of the nation's top 60 healthcare firms in Medical Marketing & Media's annual "Agency Issue" review, published this month.

The rankings, based on estimated revenue for 2007, place MicroMass among some of the largest advertising powerhouses in the country and underscore the value of the agency's unique services. MicroMass specializes in applying behavioral science -- the study of how individuals make decisions, communicate and act -- to the development of relationship marketing campaigns that build strong, influential bonds between customers and brands.

"This is what sets us apart from other agencies and fuels our success," said Jay Bigelow, president of MicroMass. "Teaming trained behaviorists with seasoned strategists, creatives, account managers and a full digital staff gives us unrivalled capabilities in generating true engagement with customers."

The agency's financial growth is linked to its parallel growth in accounts, physical space and staff. MicroMass won seven new assignments in 2007.

The company also doubled the size of its headquarters in Cary, N.C., and opened a new "pharma corridor" office in Morristown, N.J. Strategic new hires, including key senior-level additions to its leadership team, have strengthened the agency's human capital and positioned MicroMass for continued growth and expansion.

Founded in 1994, MicroMass has experience in more than 30 therapeutic categories and a client list that includes Auxilium, Bowflex, GlaxoSmithKline, Johnson & Johnson, LabCorp, Merck, Novartis, Salix, Shire and UCB Pharma. Agency services include behavioral science research and strategy; professional and consumer relationship marketing; strategic account planning; creative strategy development and execution; measureme
'/>"/>

SOURCE MicroMass Communications, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cartesian Gridspeed Opens Subsidiary Operation in North America
3. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
4. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
5. Immunotec Inc. announces appointment of President & CEO James A. Northrop
6. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
7. Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
8. Rabobank Releases Annual North American Food & Agribusiness Outlook
9. Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America
10. Medefield Announces New Appointments to North American Business Unit
11. Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 BioHealth Innovation, Inc. (BHI), ... innovations and increasing access to early-stage funding in ... capitalist, Tania Fernandez , Ph.D., has joined the ... be a member of the management team for a ... $50 million in seed and early-stage equity investments to ...
(Date:9/30/2014)... iLab Solutions announced the results of ... which focuses on core facility operations, growth and utilization ... today. , In its 4th year running, a number ... the year-over-year decrease in the percentage of revenue that ... feeling the constraints of this trend. When asked, “What ...
(Date:9/30/2014)... The custom stainless steel fabrication company ... 2014. The Boston Area Chapter of ISPE (International Society ... event for Wed., Oct. 1 at Gillette Stadium Clubhouse ... largest in ISPE Boston’s long history, with more than ... expected. , HOLLOWAY AMERICA President David Simpson is ...
(Date:9/30/2014)... Boston, MA (PRWEB) September 30, 2014 ... communications (UC) and collaboration company is dedicated to ... data connectivity needs. Julie Power, a ... team to ensure collaboration solutions stays connected and ... response to the increased movement of businesses to ...
Breaking Biology Technology:Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 3SoundConnect Expands Carrier Services Division 2
... (Nasdaq: AMLN ) issued the following statement ... Eastbourne Capital Management, L.L.C., made public earlier today:"After significant ... unable to achieve a settlement with Eastbourne and Carl ... shareholders. Of course, we continue to remain open to ...
... ATLANTA, May 20 Germany will present itself ... locations at this year,s BIO,International Convention. Under the ... will provide invaluable insight into the,latest research results ... The,German research landscape and the regulatory framework conditions ...
... N.C., May 20 Asymchem Laboratories, Inc., a leading ... Products to the pharmaceutical industry, with sites in ... the recent addition of Dr. Chris Huber as ... the table over 15 years experience in the ...
Cached Biology Technology:Amylin Responds to Eastbourne Letter 2Amylin Responds to Eastbourne Letter 3Amylin Responds to Eastbourne Letter 4BIO International Convention 2009: Research Location Germany Presents Potential in Regenerative Medicine 2Dr. Chris Huber Joins Asymchem Laboratories Inc. as Director of Chemical Development 2
(Date:9/30/2014)... The New England Journal of Medicine reports ... the drug crizotinib against the subset of lung cancer ... multi-center study of 50 patients with advanced non-small cell ... response rate was 72 percent, with 3 complete responses ... time it takes for the disease to resume its ...
(Date:9/30/2014)... (LMU) in Munich report that a new class ... to chemotherapeutic drugs. They have also pinpointed the ... for anti-tumor agents. , Researchers led by ... of the Technische Universitt Mnchen have identified a ... weapon in the fight against malignant tumors. The ...
(Date:9/30/2014)... of perilous threats in today,s ocean. From overfishing ... fragile coral ecosystems are disappearing at unprecedented rates ... of corals surrounding the island of Moorea in ... tropical environment: coral guard-crabs. New research from the ... scientist Seabird McKeon and the museum,s predoctoral fellow ...
Breaking Biology News(10 mins):NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2Cancer therapy: Driving cancer cells to suicide 2Smithsonian scientists discover coral's best defender against an army of sea stars 2
... recent study led by scientists from the National University of ... Spinal Muscular Atrophy (SMA), a devastating disease that is the ... young adults. As there is currently no known cure for ... fight against SMA. SMA is caused by deficiencies ...
... , Dec. 18, 2013 Tissue engineering ... a regenerative or reparative medicine with potential to ... engineering, which involve leveraging technologies from biomaterials, molecular ... the restructure and/or repair of human organs through ...
... have shown for the first time that the specialised role ... cilia tiny hair-like structures protruding from a cell. Stem ... body through the process of differentiation. The discovery ... therapies for a range of medical treatments where scientists aim ...
Cached Biology News:Study led by NUS scientists provides new insights into cause of human neurodegenerative disease 2Study led by NUS scientists provides new insights into cause of human neurodegenerative disease 3State-of-the-Art Tissue Engineering and Organ Regeneration Technologies Yield Healthcare Market Disruption 2State-of-the-Art Tissue Engineering and Organ Regeneration Technologies Yield Healthcare Market Disruption 3State-of-the-Art Tissue Engineering and Organ Regeneration Technologies Yield Healthcare Market Disruption 4
Features , Designed to assist users in applying domed caps to tube strips and plates , Minimises the pressure required to seal the caps effectively , Enables multiple tubes to be sealed simultaneousl...
Lysozyme C (W-20)...
... and BR4i refrigerated multifunction centrifuges are equally capable ... a low sound level with a large range ... AUTO-LOCK rotor exchange system without tools ensures that ... seconds. Instant rotor exchange (5 sec.) ...
... X-Gal (5-bromo-4-chloro-3-indoyl-beta-D-galactopyranoside) is a ... identify recombinant plasmids. In ... and IPTG, lac ... blue, whereas recombinant colonies ...
Biology Products: